DOCUSIGN director exercises 729 RSUs into stock
DOCUSIGN, INC. director Enrique T. Salem reported an automatic conversion of equity awards rather than an open-market trade.
Rhea-AI Filing Summary
DOCUSIGN, INC. director Enrique T. Salem reported an automatic conversion of equity awards rather than an open-market trade. On February 28, 2026, he exercised 729 Restricted Stock Units (RSUs), which converted into 729 shares of common stock at a price of $0.00 per share. After this conversion, his directly held common stock position rose to 166,589 shares.
Each RSU represents the right to receive one share of common stock. The underlying RSU grant has a vest commencement date of May 29, 2025 and vests in equal quarterly installments over one year, with the final installment vesting on the earlier of the next annual stockholder meeting or the one-year anniversary of the grant, subject to continued service. The RSUs themselves do not expire.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 729 | $0.00 | $0.00 |
| Exercise | Common Stock | 729 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- F2. The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date. The RSUs do not expire.
FAQ
What insider activity did DOCUSIGN (DOCU) report for Enrique T. Salem?
What type of security did Enrique T. Salem exercise in the DOCUSIGN (DOCU) filing?
What is the vesting schedule for Enrique T. Salem’s DOCUSIGN (DOCU) RSUs?
AI-generated analysis. How Rhea-AI works. Not financial advice.